Pre- to Post-Contrast Breast MRI Synthesis for Enhanced Tumour Segmentation

2311.10879

YC

0

Reddit

0

Published 6/3/2024 by Richard Osuala, Smriti Joshi, Apostolia Tsirikoglou, Lidia Garrucho, Walter H. L. Pinaya, Oliver Diaz, Karim Lekadir

🌀

Abstract

Despite its benefits for tumour detection and treatment, the administration of contrast agents in dynamic contrast-enhanced MRI (DCE-MRI) is associated with a range of issues, including their invasiveness, bioaccumulation, and a risk of nephrogenic systemic fibrosis. This study explores the feasibility of producing synthetic contrast enhancements by translating pre-contrast T1-weighted fat-saturated breast MRI to their corresponding first DCE-MRI sequence leveraging the capabilities of a generative adversarial network (GAN). Additionally, we introduce a Scaled Aggregate Measure (SAMe) designed for quantitatively evaluating the quality of synthetic data in a principled manner and serving as a basis for selecting the optimal generative model. We assess the generated DCE-MRI data using quantitative image quality metrics and apply them to the downstream task of 3D breast tumour segmentation. Our results highlight the potential of post-contrast DCE-MRI synthesis in enhancing the robustness of breast tumour segmentation models via data augmentation. Our code is available at https://github.com/RichardObi/pre_post_synthesis.

Create account to get full access

or

If you already have an account, we'll log you in

Overview

  • This study explores the feasibility of producing synthetic contrast enhancements in dynamic contrast-enhanced MRI (DCE-MRI) of the breast without the need for contrast agents.
  • The researchers leverage a generative adversarial network (GAN) to translate pre-contrast T1-weighted fat-saturated breast MRI scans to their corresponding first DCE-MRI sequence.
  • They also introduce a new metric called the Scaled Aggregate Measure (SAMe) to quantitatively evaluate the quality of the synthetic data.
  • The generated DCE-MRI data is assessed using image quality metrics and applied to the task of 3D breast tumour segmentation, demonstrating the potential for data augmentation to improve the robustness of tumour detection models.

Plain English Explanation

Dynamic contrast-enhanced MRI (DCE-MRI) is a powerful medical imaging technique that can help detect and monitor tumours. However, the use of contrast agents in DCE-MRI can be problematic, as they can be invasive, accumulate in the body, and even pose a risk of a rare condition called nephrogenic systemic fibrosis.

To address these issues, the researchers in this study explored a way to generate synthetic contrast enhancements in DCE-MRI without actually using contrast agents. They did this by using a type of artificial intelligence called a generative adversarial network (GAN) to "translate" pre-contrast MRI scans (which don't require contrast agents) into the first sequence of a DCE-MRI scan.

The researchers also developed a new way to measure the quality of the synthetic DCE-MRI data they generated, called the Scaled Aggregate Measure (SAMe). This allowed them to evaluate how well the GAN was performing and select the best model.

Finally, the researchers tested the usefulness of the synthetic DCE-MRI data by applying it to the task of detecting and delineating tumours in 3D breast MRI scans. They found that using the synthetic data to supplement the real data could help make tumour detection algorithms more robust and reliable.

Overall, this research suggests that it may be possible to generate realistic synthetic contrast enhancements in DCE-MRI without actually using contrast agents. This could be a valuable tool for improving medical imaging and tumour detection, while also avoiding the drawbacks of traditional contrast-enhanced MRI.

Technical Explanation

The researchers in this study explored the feasibility of producing synthetic contrast enhancements in dynamic contrast-enhanced MRI (DCE-MRI) of the breast. They leveraged the capabilities of a generative adversarial network (GAN) to translate pre-contrast T1-weighted fat-saturated breast MRI scans to their corresponding first DCE-MRI sequence.

The core of their approach was to train the GAN model to learn the mapping between pre-contrast MRI scans and the initial contrast-enhanced images in a DCE-MRI series. By doing so, the model could then generate synthetic DCE-MRI data without the need for actual contrast agent administration.

To quantitatively evaluate the quality of the synthetic data, the researchers introduced a new metric called the Scaled Aggregate Measure (SAMe). This metric allowed them to assess various aspects of the generated images, such as their contrast, sharpness, and similarity to real DCE-MRI data. The SAMe score served as a basis for selecting the optimal generative model.

The team then applied the generated DCE-MRI data to the task of 3D breast tumour segmentation, using it to augment the training data for a tumour detection algorithm. Their results demonstrated the potential of this synthetic data to enhance the robustness of breast tumour segmentation models, potentially improving breast cancer grade prediction and optimizing synthetic correlated diffusion imaging for breast cancer applications.

Critical Analysis

The researchers acknowledged several limitations and areas for further research in their paper. One key limitation is that the study was focused on the breast, and the feasibility of their approach for other anatomical regions remains to be explored. Additionally, the researchers noted that the generated DCE-MRI data may not fully capture the complex contrast kinetics observed in real clinical data, and further advancements in GAN architectures and training strategies may be needed to address this.

Another potential concern is the reliance on the newly introduced SAMe metric for evaluating the synthetic data. While the researchers provided a thorough explanation of this metric, its widespread adoption and validation in the medical imaging community remains to be seen. It would be valuable to compare the SAMe-based evaluations with assessments by human experts or other established image quality metrics.

Furthermore, the researchers did not provide an in-depth analysis of the potential clinical implications and limitations of using synthetic DCE-MRI data for tumour segmentation. It would be important to understand the specific scenarios where such synthetic data could be beneficial, as well as the potential risks or biases that could be introduced when relying on this type of data for diagnostic or treatment decisions.

Overall, the work presented in this paper is a promising step towards addressing the challenges associated with contrast agent administration in DCE-MRI. However, further research and validation will be necessary to fully establish the clinical utility and robustness of this approach across a wider range of medical imaging applications.

Conclusion

This study explored the feasibility of producing synthetic contrast enhancements in dynamic contrast-enhanced MRI (DCE-MRI) of the breast using a generative adversarial network (GAN). The researchers were able to translate pre-contrast MRI scans into their corresponding first DCE-MRI sequence, potentially eliminating the need for contrast agent administration.

The researchers also introduced a new metric, the Scaled Aggregate Measure (SAMe), to quantitatively evaluate the quality of the generated synthetic data. When applied to the task of 3D breast tumour segmentation, the synthetic DCE-MRI data demonstrated the potential to enhance the robustness of tumour detection algorithms through data augmentation.

While this research is promising, further validation and exploration of the clinical implications and limitations of this approach will be necessary. Nonetheless, the ability to generate realistic synthetic contrast enhancements without the use of contrast agents could have significant implications for improving medical imaging and tumour detection, while also addressing the issues associated with traditional contrast-enhanced MRI.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Related Papers

CAVM: Conditional Autoregressive Vision Model for Contrast-Enhanced Brain Tumor MRI Synthesis

CAVM: Conditional Autoregressive Vision Model for Contrast-Enhanced Brain Tumor MRI Synthesis

Lujun Gui, Chuyang Ye, Tianyi Yan

YC

0

Reddit

0

Contrast-enhanced magnetic resonance imaging (MRI) is pivotal in the pipeline of brain tumor segmentation and analysis. Gadolinium-based contrast agents, as the most commonly used contrast agents, are expensive and may have potential side effects, and it is desired to obtain contrast-enhanced brain tumor MRI scans without the actual use of contrast agents. Deep learning methods have been applied to synthesize virtual contrast-enhanced MRI scans from non-contrast images. However, as this synthesis problem is inherently ill-posed, these methods fall short in producing high-quality results. In this work, we propose Conditional Autoregressive Vision Model (CAVM) for improving the synthesis of contrast-enhanced brain tumor MRI. As the enhancement of image intensity grows with a higher dose of contrast agents, we assume that it is less challenging to synthesize a virtual image with a lower dose, where the difference between the contrast-enhanced and non-contrast images is smaller. Thus, CAVM gradually increases the contrast agent dosage and produces higher-dose images based on previous lower-dose ones until the final desired dose is achieved. Inspired by the resemblance between the gradual dose increase and the Chain-of-Thought approach in natural language processing, CAVM uses an autoregressive strategy with a decomposition tokenizer and a decoder. Specifically, the tokenizer is applied to obtain a more compact image representation for computational efficiency, and it decomposes the image into dose-variant and dose-invariant tokens. Then, a masked self-attention mechanism is developed for autoregression that gradually increases the dose of the virtual image based on the dose-variant tokens. Finally, the updated dose-variant tokens corresponding to the desired dose are decoded together with dose-invariant tokens to produce the final contrast-enhanced MRI.

Read more

6/26/2024

📈

Synthetic Brain Images: Bridging the Gap in Brain Mapping With Generative Adversarial Model

Drici Mourad, Kazeem Oluwakemi Oseni

YC

0

Reddit

0

Magnetic Resonance Imaging (MRI) is a vital modality for gaining precise anatomical information, and it plays a significant role in medical imaging for diagnosis and therapy planning. Image synthesis problems have seen a revolution in recent years due to the introduction of deep learning techniques, specifically Generative Adversarial Networks (GANs). This work investigates the use of Deep Convolutional Generative Adversarial Networks (DCGAN) for producing high-fidelity and realistic MRI image slices. The suggested approach uses a dataset with a variety of brain MRI scans to train a DCGAN architecture. While the discriminator network discerns between created and real slices, the generator network learns to synthesise realistic MRI image slices. The generator refines its capacity to generate slices that closely mimic real MRI data through an adversarial training approach. The outcomes demonstrate that the DCGAN promise for a range of uses in medical imaging research, since they show that it can effectively produce MRI image slices if we train them for a consequent number of epochs. This work adds to the expanding corpus of research on the application of deep learning techniques for medical image synthesis. The slices that are could be produced possess the capability to enhance datasets, provide data augmentation in the training of deep learning models, as well as a number of functions are made available to make MRI data cleaning easier, and a three ready to use and clean dataset on the major anatomical plans.

Read more

4/16/2024

Evaluating the Impact of Sequence Combinations on Breast Tumor Segmentation in Multiparametric MRI

Evaluating the Impact of Sequence Combinations on Breast Tumor Segmentation in Multiparametric MRI

Hang Min, Gorane Santamaria Hormaechea, Prabhakar Ramachandran, Jason Dowling

YC

0

Reddit

0

Multiparametric magnetic resonance imaging (mpMRI) is a key tool for assessing breast cancer progression. Although deep learning has been applied to automate tumor segmentation in breast MRI, the effect of sequence combinations in mpMRI remains under-investigated. This study explores the impact of different combinations of T2-weighted (T2w), dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) map on breast tumor segmentation using nnU-Net. Evaluated on a multicenter mpMRI dataset, the nnU-Net model using DCE sequences achieved a Dice similarity coefficient (DSC) of 0.69 $pm$ 0.18 for functional tumor volume (FTV) segmentation. For whole tumor mask (WTM) segmentation, adding the predicted FTV to DWI and ADC map improved the DSC from 0.57 $pm$ 0.24 to 0.60 $pm$ 0.21. Adding T2w did not yield significant improvement, which still requires further investigation under a more standardized imaging protocol. This study serves as a foundation for future work on predicting breast cancer treatment response using mpMRI.

Read more

6/13/2024

Towards Learning Contrast Kinetics with Multi-Condition Latent Diffusion Models

Towards Learning Contrast Kinetics with Multi-Condition Latent Diffusion Models

Richard Osuala, Daniel Lang, Preeti Verma, Smriti Joshi, Apostolia Tsirikoglou, Grzegorz Skorupko, Kaisar Kushibar, Lidia Garrucho, Walter H. L. Pinaya, Oliver Diaz, Julia Schnabel, Karim Lekadir

YC

0

Reddit

0

Contrast agents in dynamic contrast enhanced magnetic resonance imaging allow to localize tumors and observe their contrast kinetics, which is essential for cancer characterization and respective treatment decision-making. However, contrast agent administration is not only associated with adverse health risks, but also restricted for patients during pregnancy, and for those with kidney malfunction, or other adverse reactions. With contrast uptake as key biomarker for lesion malignancy, cancer recurrence risk, and treatment response, it becomes pivotal to reduce the dependency on intravenous contrast agent administration. To this end, we propose a multi-conditional latent diffusion model capable of acquisition time-conditioned image synthesis of DCE-MRI temporal sequences. To evaluate medical image synthesis, we additionally propose and validate the Fr'echet radiomics distance as an image quality measure based on biomarker variability between synthetic and real imaging data. Our results demonstrate our method's ability to generate realistic multi-sequence fat-saturated breast DCE-MRI and uncover the emerging potential of deep learning based contrast kinetics simulation. We publicly share our accessible codebase at https://github.com/RichardObi/ccnet and provide a user-friendly library for Fr'echet radiomics distance calculation at https://pypi.org/project/frd-score.

Read more

5/2/2024